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LETTER TO THE EDITOR
GENETIC DIVERSITY OF MEASLES VIRUS - RESURGENCE OF  
NEW GENOTYPE D8 IN SAO PAULO, BRAZIL
Sao Paulo, April 28, 2014
Dear Sir:
Measles virus (MV) has been under control in Brazil because of the 
high coverage rates of immunization. Emphasized by the measles control 
global program at the Pan American Health Organization, with the use 
of several strategies of vaccination programs to reduce the number of 
circulating chains of transmission of the virus, these programs have 
successfully decreased the incidence of measles on a global scale. 
However, measles outbreaks still occasionally occur in areas with high 
vaccine coverage as a result of imported transmission1,2. 
For the goal of MV elimination, genotypes characterization of 
circulating wild-type MV is useful to document the interruption of 
transmission of endemic measles infection. In a meeting organized by 
the World Health Organization (1998), a nomenclature of MV genotypes 
and the targets for molecular epidemiological studies were established. 
Currently, 24 genotypes of MV have been identified and they have been 
distributed by geographical patterns6,7.
The Epidemiologic Surveillance Center and Adolfo Lutz Institute in 
São Paulo are consistent in the investigation and continuous analysis of 
the activity of the measles control program. Retrospective studies of the 
genetic diversity of MV in São Paulo indicated that genotypes D5 had 
been registered in 1995 and 1996 and that the circulation of genotypes 
D6 was responsible for the 1997 epidemic5. After this period, the MV 
was interrupted with the absence of endemic genotypes. However, cases 
of imported virus were registered - genotype D5 in 2000, 2001 and 2005, 
genotype D4 in 2011 and genotype D8 in 2012 and 20132,3,4.
A resurgence of indigenous MV cases has occurred in Sao Paulo in 
2014. A total of 90 patients suspected of MV infection were analyzed 
for measles-specific immunoglobulin (IgM) by Elisa and Real-time 
quantitative PCR. Of these patients, MV infections were confirmed 
in seven cases. They did not receive the vaccine nor had any record of 
vaccination for MV; regarding age, patients were between eight month-
old and 34 years-old. 
The genetic analysis was carried out from the seven confirmed 
measles cases. The sequences of N gene were determined by means of 
comparison with those from the GenBank reference strains. The results 
in five cases showed the presence of genotypes D8, a new genotype 
circulating in Sao Paulo. This genotype had been previously reported 
with an imported case in 2012 and 2013. In one of these cases, the 
patient had traveled to Fortaleza (Brazil), where MV genotype D8 had 
been circulating, and returned to Sao Paulo. 
In addition, we conducted the analysis of two imported cases, which 
the surveillance had reported as patients who had traveled to Europe and 
returned to Sao Paulo presenting symptoms. The phylogenetic analysis 
of one of these cases showed that MVs were genotype B3 and that the 
other case was confirmed only by IgM and 4-fold increase in the IgG 
antibody titer in acute and convalescent serum specimens.
The government has been making great efforts to achieve the goal 
of measles elimination adopting surveillance programs to implement 
investigation strategies in susceptible populations and others to improve 
supplemental immunization.
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